UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Paclitaxel‑resistant gastric cancer MGC‑803 cells promote epithelial‑to‑mesenchymal transition and chemoresistance in paclitaxel‑sensitive cells via exosomal delivery of miR‑155‑5p

International journal of oncology, 2019-01, Vol.54 (1), p.326-338

2019

Volltextzugriff (PDF)

Exosomes: decreased sensitivity of lung cancer A549 cells to cisplatin

PloS one, 2014-02, Vol.9 (2), p.e89534-e89534

2014

Volltextzugriff (PDF)

B7-H4 and HHLA2, members of B7 family, are aberrantly expressed in EGFR mutated lung adenocarcinoma

Pathology, research and practice, 2020-10, Vol.216 (10), p.153134-153134, Article 153134

2020

Volltextzugriff (PDF)

Comparison of Efficacy and Safety of First-Line Treatment Options for Unresectable Stage III Non-Small Cell Lung Cancer: A Retrospective Analysis

International journal of clinical practice (Esher), 2024, Vol.2024, p.8585035-10

2024

Volltextzugriff (PDF)

A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy

Frontiers in oncology, 2021-07, Vol.11, p.692703-692703

2021

Volltextzugriff (PDF)

Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation

Cancer cell international, 2020-03, Vol.20 (1), p.90-90

2020

Volltextzugriff (PDF)

Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study

Frontiers in oncology, 2023-01, Vol.12, p.1036906

2023

Volltextzugriff (PDF)

Comparison of Efficacy and Safety of Second-Line Treatment Options for Advanced Small-Cell Lung Cancer: A Retrospective Analysis

Technology in cancer research & treatment, 2024-01, Vol.23, p.15330338241227055

2024

Volltextzugriff (PDF)

Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia

Frontiers in oncology, 2020-01, Vol.9, p.1509-1509

2020

Volltextzugriff (PDF)

Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment

Frontiers in oncology, 2023-09, Vol.13, p.1169333-1169333

2023

Volltextzugriff (PDF)

Comment on "Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial"

Journal of thoracic oncology, 2024-01, Vol.19 (1), p.173-174

2024

Volltextzugriff (PDF)

Retraction Note to: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation

Cancer cell international, 2021-01, Vol.21 (1), p.40-40, Article 40

2021

Volltextzugriff (PDF)

Colorectal cancer patients with low abundance of KRAS mutation may benefit from EGFR antibody therapy

PloS one, 2013-07, Vol.8 (7), p.e68022-e68022

2013

Volltextzugriff (PDF)

Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation

Tumor biology, 2017-03, Vol.39 (3), p.1010428317691659-1010428317691659

2017

Volltextzugriff (PDF)

Tumor-derived exosomes in cancer progression and treatment failure

Oncotarget, 2015-11, Vol.6 (35), p.37151-37168

2015

Volltextzugriff (PDF)

A hybrid unsupervised learning approach for noise removal in particle image velocimetry

Physics of fluids (1994), 2024-11, Vol.36 (11)

2024

Volltextzugriff (PDF)

Cell-free miR-24 and miR-30d, potential diagnostic biomarkers in malignant effusions

Clinical biochemistry, 2011-02, Vol.44 (2), p.216-220

2011

Volltextzugriff (PDF)

Anti-PD-1 antibody monotherapy or anti-PD-1 antibody combination with chemotherapy treated non-small cell lung cancer (NSCLC) patients with EGFR mutation: A retrospective analysis

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e21691-e21691

2020

Volltextzugriff (PDF)

Modified PNA-PCR method: A convenient and accurate method to screen plasma KRAS mutations of cancer patients

Cancer biology & therapy, 2012-03, Vol.13 (5), p.314-320

2012

Volltextzugriff (PDF)

Coamplification at lower denaturation temperature polymerase chain reaction enables selective identification of K- Ras mutations in formalin-fixed, paraffin-embedded tumor tissues without tumor-cell enrichment

Human pathology, 2011-09, Vol.42 (9), p.1312-1318

2011

Volltextzugriff (PDF)

Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner

International journal of nanomedicine, 2017-01, Vol.12, p.3721-3733

2017

Volltextzugriff (PDF)

Long non-coding RNA FBXL19-AS1 plays oncogenic role in colorectal cancer by sponging miR-203

Biochemical and biophysical research communications, 2017-06, Vol.488 (1), p.67-73

2017

Volltextzugriff (PDF)

Comparative analysis of microRNA expression profiles between A549, A549/DDP and their respective exosomes

Oncotarget, 2017-06, Vol.8 (26), p.42125-42135

2017

Volltextzugriff (PDF)

EGFR E746-A750 deletion in lung cancer represses antitumor immunity through the exosome-mediated inhibition of dendritic cells

Oncogene, 2020-03, Vol.39 (13), p.2643-2657

2020

Volltextzugriff (PDF)

CircATXN7 regulates the proliferation and invasion of esophageal cancer cells through miR-4319/NLRC5

Cellular signalling, 2024-10, Vol.122, p.111341, Article 111341

2024

Volltextzugriff (PDF)

1 – 25 von 386

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(313)
Mit Volltextzugriff
(348)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(296)
Life Sciences & Biomedicine
(132)
Technology
(104)
Animals
(71)
Physical Sciences
(71)
Mice
(60)
Humans
(59)
Engineering
(56)
Chemistry
(52)
Cell Biology
(46)
Oncology
(43)
Female
(37)
Science & Technology - Other Topics
(33)
Male
(31)
Materials Science
(31)
Engineering, Electrical & Electronic
(26)
Biochemistry & Molecular Biology
(24)
Gene Expression
(24)
Stem Cells
(23)
Computer Science
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Paclitaxel‑resistant gastric cancer MGC‑803 cells promote epithelial‑to‑mesenchymal transition and chemoresistance in paclitaxel‑sensitive cells via exosomal delivery of miR‑155‑5p

Exosomes: decreased sensitivity of lung cancer A549 cells to cisplatin

B7-H4 and HHLA2, members of B7 family, are aberrantly expressed in EGFR mutated lung adenocarcinoma

Comparison of Efficacy and Safety of First-Line Treatment Options for Unresectable Stage III Non-Small Cell Lung Cancer: A Retrospective Analysis

A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy

Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation

Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study

Comparison of Efficacy and Safety of Second-Line Treatment Options for Advanced Small-Cell Lung Cancer: A Retrospective Analysis

Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia

Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment

Comment on "Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial"

Retraction Note to: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation

Colorectal cancer patients with low abundance of KRAS mutation may benefit from EGFR antibody therapy

Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation

Tumor-derived exosomes in cancer progression and treatment failure

A hybrid unsupervised learning approach for noise removal in particle image velocimetry

Cell-free miR-24 and miR-30d, potential diagnostic biomarkers in malignant effusions

Anti-PD-1 antibody monotherapy or anti-PD-1 antibody combination with chemotherapy treated non-small cell lung cancer (NSCLC) patients with EGFR mutation: A retrospective analysis

Modified PNA-PCR method: A convenient and accurate method to screen plasma KRAS mutations of cancer patients

Coamplification at lower denaturation temperature polymerase chain reaction enables selective identification of K- Ras mutations in formalin-fixed, paraffin-embedded tumor tissues without tumor-cell enrichment

Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner

Long non-coding RNA FBXL19-AS1 plays oncogenic role in colorectal cancer by sponging miR-203

Comparative analysis of microRNA expression profiles between A549, A549/DDP and their respective exosomes

EGFR E746-A750 deletion in lung cancer represses antitumor immunity through the exosome-mediated inhibition of dendritic cells

CircATXN7 regulates the proliferation and invasion of esophageal cancer cells through miR-4319/NLRC5

Suchergebnisse filtern